Ascendis Pharma A (ASND) Times Interest Earned (2014 - 2026)

Ascendis Pharma A has disclosed Times Interest Earned across 13 years of filings, most recently posting $0.37 for Q1 2026.

• Times Interest Earned for Q1 2026 came in at $0.37, down 84.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.19 (up 100.0% YoY), and the FY2025 annual result was -$0.66, up 76.34% from the prior year.
• Times Interest Earned came in at $0.37 for Q1 2026 at Ascendis Pharma A, up from -$0.16 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $478.53 in Q4 2022 to a low of -$29.5 million in Q4 2024.
• The 5-year median for Times Interest Earned is -$1.6 (2025), against an average of -$1.7 million.
• Across the five-year window, Times Interest Earned plunged 5172869859.87% in 2024 and jumped 465.34% in 2025, its largest moves.
• Ascendis Pharma A's Times Interest Earned stood at $478.53 in 2022, then tumbled by 100.12% to -$0.57 in 2023, then slumped by 5172869859.87% to -$29.5 million in 2024, then jumped by 100.0% to -$0.16 in 2025, then jumped by 331.1% to $0.37 in 2026.
• The last three Times Interest Earned figures came in at $0.37 (Q1 2026), -$0.16 (Q4 2025), and -$0.16 (Q3 2025), per Business Quant data.